Analysis of clinical characteristics and factors influencing herpes simplex virus keratitis
- PMID: 38293295
- PMCID: PMC10824927
- DOI: 10.3389/fmed.2023.1267783
Analysis of clinical characteristics and factors influencing herpes simplex virus keratitis
Abstract
Objective: To investigate the clinical characteristics and factors associated with herpes simplex virus keratitis.
Methods: Patients with herpes simplex virus keratitis who came to our hospital from January 2018 to June 2022 were selected and divided into a good prognosis group and a poor prognosis group according to their prognosis. The clinical data of the two groups were compared, and univariate/multivariate logistic regression was used to analyze the factors influencing the poor prognosis of herpes simplex virus keratitis.
Results: A one-way analysis of variance showed that, compared with the good prognosis group, the poor prognosis group had more elderly patients and a longer course of disease, and the difference was statistically significant (p < 0.05). There were significant differences in the types of patients between the two groups (p < 0.05). Univariate logistic regression analysis also showed that age (≥65 years) (OR: 1.557, 95%CI: 1.081-2.183, p < 0.05), course of disease (> 7 months) (OR: 1.303, 95%CI: 1.003-1.829, p < 0.05), epithelial type (OR: 2.321, 95%CI: 1.198-4.321, p < 0.05), and stromal type (OR: 2.536, 95%CI: 1.672-3.871, p < 0.05) were risk factors for poor prognosis. Multivariate logistic regression analysis showed that age (≥65 years) (OR: 1.656, 95%CI: 1.168-2.357, p < 0.05) and course of disease (> 7 months) (OR: 1.461, 95%CI: 1.031-2.001, p < 0.05) were independent risk factors for the prognosis of herpes simplex keratitis.
Conclusion: The clinical symptoms of herpes simplex virus keratitis include corneal opacity, corneal posterior elastic layer folds, corneal infiltration, posterior corneal mass, corneal edema, and ocular pain. Age and course of disease are important factors in the prognosis of herpes simplex virus keratitis.
Keywords: clinical characteristics; corneal opacity; eye pain; herpes simplex keratitis; influencing factors.
Copyright © 2024 Zhang, Mi, Ge, Wang, Zhou, Zhao and Zhao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.Invest Ophthalmol Vis Sci. 1993 Jul;34(8):2460-8. Invest Ophthalmol Vis Sci. 1993. PMID: 8392037
-
Keratitis in children as seen in a tertiary hospital in Africa.J Natl Med Assoc. 2008 Apr;100(4):386-90. doi: 10.1016/s0027-9684(15)31270-0. J Natl Med Assoc. 2008. PMID: 18481476
-
Reactivation of Herpes Simplex Keratitis on a Corneal Graft Following SARS-CoV-2 mRNA Vaccination.Med Arch. 2022 Apr;76(2):146-148. doi: 10.5455/medarh.2022.76.146-148. Med Arch. 2022. PMID: 35774041 Free PMC article.
-
Diagnosis and management of herpes simplex stromal keratitis.Cornea. 1987;6(4):286-91. doi: 10.1097/00003226-198706040-00011. Cornea. 1987. PMID: 3319411 Review.
-
The treatment of herpes simplex virus epithelial keratitis.Trans Am Ophthalmol Soc. 2000;98:505-32. Trans Am Ophthalmol Soc. 2000. PMID: 11190039 Free PMC article.
References
LinkOut - more resources
Full Text Sources